INTECH Investment Management’s Terns Pharmaceuticals TERN Stock Holding History

INTECH Investment Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28M	Sell	24,191 -8,730	-27%	-$359K	0.01%	899
2025 Q4	$1.33M	Buy	32,921 +1,928	+6%	+$44.6K	0.01%	964
2025 Q3	$233K	Sell	30,993 -15,128	-33%	-$96.6K	﹤0.01%	1977
2025 Q2	$172K	Buy	46,121 +6,199	+16%	+$19.4K	﹤0.01%	2140
2025 Q1	$110K	Buy	39,922 +21,451	+116%	+$87.6K	﹤0.01%	2290
2024 Q4	$102K	Buy	18,471 +1,102	+6%	+$7.46K	﹤0.01%	2209
2024 Q3	$145K	Buy	+17,369	New	+$143K	﹤0.01%	1814

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

INTECH Investment Management's TERN Position: Q1 2026 in Review

INTECH Investment Management reduced its Terns Pharmaceuticals (TERN) stake by 27% in Q1 2026, selling an estimated $359K and leaving 24,191 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #899.

INTECH Investment Management first reported a position in TERN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.33M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

INTECH Investment Management held 24,191 shares of Terns Pharmaceuticals worth $1.28M as of Q1 2026.
INTECH Investment Management sold 8,730 Terns Pharmaceuticals shares in Q1 2026, an estimated $359K.
Terns Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #899 holding.
INTECH Investment Management first reported a position in Terns Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
INTECH Investment Management's Terns Pharmaceuticals position peaked at $1.33M in Q4 2025.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.